Exercising with AID Systems: Practical Tips for Planned and Unplanned Activity with Dr. Desi Zaharieva

Omnipod® 5's 100 mg/dL Target Glucose setting and FreeStyle Libre 3 Plus sensor integration

Omnipod 5 is now even stronger with enhancements designed for more time in range1 and more time in Automated Mode. In this episode, we break down what they are and what they look like in practice. Hosts Dena Gottesman MS, RD, CDCES and Nancy Hanna RN, BSN, CDE are joined by Dr. Nader Kassam, a pediatric endocrinologist at Corewell Health living with type 1 diabetes, to explore the latest updates coming to Omnipod 5. Dr. Kassam shares his firsthand experience as a participant of the Limited Market Release of this product.  He shares how the new 100 mg/dL Target Glucose setting increases the algorithm’s response to rising glucose levels to help him spend more time in range1  and how these enhancements can help keep users in Automated Mode longer. The FreeStyle Libre 3 Plus sensor integration results in more personalized care and more real-time glucose monitoring data for caregivers with the LibreLinkUp app.  1. In a simulated analysis, the 100 mg/dL Target Glucose (TG) setting demonstrated superior Time in Range (70-180 mg/dL) compared with results at the 110-150 mg/dL TG settings in a real-world population of people with T1D using Omnipod 5. Differences in mean TIR for 100mg/dL vs 110mg/dL, vs 120 mg/dL, vs 130 mg/dL, vs 140 mg/dL, vs 150 mg/dL, were 2.5%, 4.8%, 9.8%, 15.3%, and 20.8%, respectively. For each comparison, the lower bound of the one-sided 95% Confidence Interval (CI) was >0%, meeting the pre-specified superiority criterion. Analysis not controlled for ISF, ICR, % time in Automated Mode and number of bolus/day. Data on File. RF-012026-00057. 2:33 – More TIR with the 100mg/dL Target Glucose setting1 6:04 – How adjustable Target Glucose settings support confidence in day-to-day diabetes management 10:30 – Algorithm improvements designed for more time in Automated Mode      14:41 – Sensor choice and how some Libre 3 Plus sensor choice can help families simplify care   1. In a simulated analysis, the 100 mg/dL Target Glucose (TG) setting demonstrated superior Time in Range (70-180 mg/dL) compared with results at the 110-150 mg/dL TG settings in a real-world population of people with T1D using Omnipod 5. Differences in mean TIR for 100mg/dL vs 110mg/dL, vs 120 mg/dL, vs 130 mg/dL, vs 140 mg/dL, vs 150 mg/dL, were 2.5%, 4.8%, 9.8%, 15.3%, and 20.8%, respectively. For each comparison, the lower bound of the one-sided 95% Confidence Interval (CI) was >0%, meeting the pre-specified superiority criterion. Analysis not controlled for ISF, ICR, % time in Automated Mode and number of bolus/day. Data on File. RF-012026-00057. Standard additional description for SEO purposes: [MU2] How [MU3] do medical devices like Omnipod 5 improve the lives of people living with diabetes? How can Healthcare Professionals implement Omnipod 5 Automated Insulin Delivery (AID) Systems in practice? Beyond the Bolus is a US-based diabetes education podcast for healthcare professionals who treat patients living with type 1 (t1d) and type 2 diabetes (t2d). Hosted by Insulet’s Clincial Services Mangers, Nancy Hanna RN, BSN, CDE, and Dena Gottesman MS, RD, CDCES, this dynamic duo care deeply about helping healthcare professionals (HCP)’s and patients simplify life with diabetes. Episodes cover a range of topics such as, how to get started with Omnipod 5 to ongoing care management, helping HCPs make patient conversations more efficient and effective. Beyond the Bolus also dives into the latest clinical research and data with prominent diabetes experts from across the globe who share real-world experiences and offer insights into what the future of diabetes care could look like with devices like Omnipod 5. If you’re looking to empower your patients to take back control of their diabetes, then this is the podcast for you. The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older and type 2 diabetes in persons aged 18 and older. Rx only. WARNING: Do not use SmartAdjust™ technology for people under the age of 2 or who require less than 5 U of insulin per day. Visit omnipod.com/safety for complete safety information. © 2026 Insulet Corporation. All rights reserved.

Mental Health, Automation, and Human-Centered Design: Rethinking Diabetes Care with AID Systems

Mental health, cognitive burden, and quality of life are becoming central to how we define success in diabetes care. In this episode, we explore what that shift looks like in practice. Hosts Dena Gottesman MS, RD, CDCES and Nancy Hanna RN, BSN, CDE hand over to guest host Kamil Armacki , also known as Nerdabetic, who is joined by Dr. Korey Hood, Clinical Psychologist and Professor at Stanford University, and Jen Boyd, Senior Director of Medical Affairs at Insulet. Together, they unpack the often overlooked mental and cognitive load of living with diabetes, from constant decision making and planning to sleep disruption and diabetes distress. Dr Hood shares both his clinical expertise and personal perspective as someone living with type 1 (t1d) diabetes, highlighting why these challenges are just as important as glycemic outcomes. The conversation explores how advancements in automated insulin delivery (AID) and human-centered design are helping reduce that burden. Jen Boyd discusses how simplicity, usability, and patient feedback shape the development of technologies like Omnipod 5, with a focus on removing friction from everyday diabetes management. It is a powerful reminder that diabetes care is not just about time in range, but about creating more time for living. • 03:03– Mental & cognitive burden of diabetes • 07:26 – Usability and outcomes are inseparable • 10:18 – Automated insulin delivery reduces burden and restores freedom • 18:20 – Shift from numbers to lived experience How do medical devices like Omnipod 5 improve the lives of people living with diabetes? How can Healthcare Professionals implement Omnipod 5 Automated Insulin Delivery (AID) Systems in practice? Beyond the Bolus is a US-based diabetes education podcast for healthcare professionals who treat patients living with type 1 (t1d) and type 2 diabetes (t2d). Hosted by Insulet’s Clincial Services Mangers, Nancy Hanna RN, BSN, CDE, and Dena Gottesman MS, RD, CDCES, this dynamic duo care deeply about helping healthcare professionals (HCP)’s and patients simplify life with diabetes. Episodes cover a range of topics such as, how to get started with Omnipod 5 to ongoing care management, helping HCPs make patient conversations more efficient and effective. Beyond the Bolus also dives into the latest clinical research and data with prominent diabetes experts from across the globe who share real-world experiences and offer insights into what the future of diabetes care could look like with devices like Omnipod 5. If you’re looking to empower your patients to take back control of their diabetes, then this is the podcast for you. The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older and type 2 diabetes in persons aged 18 and older. Rx only. WARNING: Do not use SmartAdjust™ technology for people under the age of 2 or who require less than 5 U of insulin per day. Visit omnipod.com/safety for complete safety information. © 2026 Insulet Corporation. All rights reserved

The Benefits of Insulet’s Pod Recycling Program

How do you make diabetes care more sustainable? We’re addressing patient concerns regarding medical waste, enhancing the sustainability profile of the practice's treatment recommendations, and fostering higher patient satisfaction with the Insulet’s Pod Recycling Program. Hosts Dena Gottesman MS, RD, CDCES and Nancy Hanna RN, BSN, CDE are joined by Lisa Brady, Vice President and Chief Sustainability Officer at Insulet, to explore how the company is tackling one of the biggest challenges in diabetes technology – waste. Lisa walks through Insulet’s Pod recycling program, which has now expanded across the United States. Omnipod® 5 users can request a simple, accessible return kit, which can hold up to 6 months' worth of Pods. Once returned, Lisa explains the decontamination process and how batteries, plastics and metals are repurposed. This global diabetes tech recycling program is the first of many sustainability initiatives enabling Insulet to take a more active role in reducing environmental impact without increasing the burden of daily diabetes care. • 01:22 – The core pillars of Insulet’s sustainability strategy • 03:49 – A step-by-step breakdown of the recycling program • 05:06 –Why Pod recycling matters to customers and the community • 09:51 – What’s next: expansion, future access, and sustainability goals -- How do medical devices like Omnipod 5 improve the lives of people living with diabetes? How can Healthcare Professionals implement Omnipod 5 Automated Insulin Delivery (AID) Systems in practice? Beyond the Bolus is a US-based diabetes education podcast for healthcare professionals who care for people living with type 1 (t1d) and type 2 diabetes (t2d). Hosted by Insulet’s Clincial Services Mangers, Nancy Hanna RN, BSN, CDE, and Dena Gottesman MS, RD, CDCES, this dynamic duo care deeply about helping healthcare professionals (HCP)’s and patients simplify life with diabetes. Episodes cover a range of topics such as, how to get started with Omnipod 5 to ongoing care management, helping HCPs make patient conversations more efficient and effective. Beyond the Bolus also dives into the latest clinical research and data with prominent diabetes experts from across the globe who share real-world experiences and offer insights into what the future of diabetes care could look like with technology like Omnipod 5. The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older and type 2 diabetes in persons aged 18 and older. Rx only. WARNING: Do not use SmartAdjust™ technology for people under the age of 2 or who require less than 5 U of insulin per day. Visit omnipod.com/safety for complete safety information. © 2026 Insulet Corporation. All rights reserved.

A Clinician Love Letter to Omnipod® 5

Hosted by Nancy Hanna and Dena Gottesman In this special Valentine’s-month episode of Beyond the Bolus, hosts Nancy Hanna and Dena Gottesman share a clinician “love letter” to the Omnipod 5 Automated Insulin Delivery System — highlighting the real-world moments, patient stories, and everyday features that healthcare providers value most. Through firsthand perspectives from clinicians who both prescribe and personally use Omnipod 5, this episode explores how automated insulin delivery is changing diabetes care. Guests share why personalization matters, how tubeless design can improve adoption, and how small features (from Custom Foods to real-time data access) can make a meaningful difference in daily diabetes management.

Exercising with AID Systems: Practical Tips for Planned and Unplanned Activity with Dr. Desi Zaharieva

In this special ADA 2025 edition of Beyond the Bolus, host Nancy Hanna sits down with Dr Dessi Zaharieva to talk about the most challenging aspects of diabetes management - Exercise. In this episode, Dr Zaharieva breaks down key takeaways from her co-authored international consensus statement on using automated insulin delivery (AID) systems during physical activity. Topics covered included how to manage planned VS unplanned exercise using AID systems, why setting a higher glucose target 1-2 hours before physical activity makes a difference and the importance of a strategic approach to carbs to help prevent hypoglycaemia. Whether you’re supporting patients in the clinic or helping them prepare for spontaneous workouts, this conversation offers evidence-based, real-world strategies to make exercise safer, simpler, and more enjoyable for people living with diabetes.